WuXi XDC Cayman Inc Sustainability Reports
The company operates as a global contract research, development, and manufacturing organization (CRDMO) focused on antibody-drug conjugates (ADCs) and the broader bioconjugate market. It provides end-to-end services ranging from discovery and development to commercial manufacturing of biologics intermediates, chemical payloads, linkers, and drug products.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 549300BV0TP5RVPBYO24
FIGI: BBG00ZVLT964
5 reports from 2023 to 2025